Vaginal Biome Science
Vaginal Biome Science (VBS) is a privately held biotechnology company specializing in microbiome-driven solutions for vaginal health. Founded in 2021 and headquartered in Portland, Oregon, VBS develops clinically validated consumer healthcare products and diagnostics based on patented BioMatch® technology, which optimizes vaginal pH and supports beneficial Lactobacillus to address vaginal dysbiosis. The company leads the VENUS Study, one of the largest observational vaginal microbiome studies in the U.S., advancing precision care across 12 gynecological conditions. VBS integrates advanced qPCR microbiome measurement, bioengineering, and AI-driven predictive models to create personalized, effective interventions that improve women's vaginal health outcomes and empower patients and healthcare providers with actionable insights. Their robust intellectual property portfolio and clinical research underpin their leadership in evidence-based women's health solutions.
Vaginal Biome Science
Vaginal Biome Science (VBS) is a privately held biotechnology company specializing in microbiome-driven solutions for vaginal health. Founded in 2021 and headquartered in Portland, Oregon, VBS develops clinically validated consumer healthcare products and diagnostics based on patented BioMatch® technology, which optimizes vaginal pH and supports beneficial Lactobacillus to address vaginal dysbiosis. The company leads the VENUS Study, one of the largest observational vaginal microbiome studies in the U.S., advancing precision care across 12 gynecological conditions. VBS integrates advanced qPCR microbiome measurement, bioengineering, and AI-driven predictive models to create personalized, effective interventions that improve women's vaginal health outcomes and empower patients and healthcare providers with actionable insights. Their robust intellectual property portfolio and clinical research underpin their leadership in evidence-based women's health solutions.